Clinical Trial of Ultra-high Dose Methylcobalamin for ALS

Clinical trial NCT03548311 · COMPLETED

Trial details

NCT number: NCT03548311
Sponsor: Eisai Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2017-11-01
Primary completion: 2020-02-14
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.